Skip to content
MedsAcross

Medicine

Ranitidine 300 mg capsule

Ranitidine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Ranitidine 300 mg capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68° F to 77°F) in a dry place. Protect from light.

Key facts

Active ingredient (INN)
Ranitidine
Brand
Sold under the generic name
Strength
300 mg
Dosage form
Capsule
Route
Oral
Packs
30 capsules, 100 capsules and 1 more
Manufacturers
Ajanta PharmaIndiaDr. Reddy's LaboratoriesIndia
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68° F to 77°F) in a dry place. Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A02BA02 Ranitidine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 April 2001
Identifiers
RxCUI 198190, 198192DailyMed set ID fb67e8c7-b817-4253-a1a1-5ecdcee694cf, 7bf94bf7-fa11-70be-9f65-fe26a3db5a63NDC 27241-110, 55111-130Application ANDA209859, ANDA075742

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 capsule in 1 bottle27241-110-03Ajanta PharmaIndia27 September 2018
100 capsule in 1 bottle27241-110-10Ajanta PharmaIndia27 September 2018
100 capsule in 1 bottle55111-130-01Dr. Reddy's LaboratoriesIndia1 April 2001
30 capsule in 1 bottle55111-130-30Dr. Reddy's LaboratoriesIndia1 April 2001

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 June 1983Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Ranitidine

Clinical summary

Ranitidine is a histamine-2 receptor antagonist indicated to date have not assessed the safety of Ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. It is available as tablets and capsules for oral use. MedsAcross supplies Ranitidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ranitidine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ranitidine 300 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.